Gilead Sciences Inc articles over last 30 days

- articles last 30 days - articles per day
Mentioned in this news Places Companies People
2014/11/26 12:45
2014/11/26 12:45
22h
Steve Miller is waging war on high- priced medicine, guiding decisions to ban drugs from the health plans of millions of Americans and sending companies reeling in a $270 billion market. He and his...
2014/11/26 12:45
2014/11/26 12:45
Latest videos
2014/11/24 08:55
2014/11/24 08:55
3d
The medicine Elizabeth “Lizzy” West of Arkansas County needs to treat her cystic fibrosis will cost about $300,000 a year for the rest of her life. West and two other Arkansas Medicaid beneficiaries...
2014/11/19 03:17
2014/11/19 03:17
8d
FOSTER CITY, Kalifornien (USA)--(BUSINESS WIRE)--Das Unternehmen Gilead Sciences, Inc. (NASDAQ: GILD), hat heute bekannt gegeben, dass es von der Europäischen Kommission die Zulassung für Harvoni®...
2014/11/19 02:17
2014/11/19 02:17
8d
Europese Commissie verleent vergunning voor het in de handel brengen voor Gilead’s Harvoni®▼ (Ledipasvir/Sofosbuvir), het eerste enkel-tabletregime voor de behandeling van patiënten met chronische...
2014/11/18 21:27
2014/11/18 21:27
8d
Nov. 18 (Bloomberg) -- It costs drugmakers $2.56 billion to bring a new medicine to market, on average, more than double the price of 11 years ago, according to a study released today. The higher...
2014/11/18 18:49
2014/11/18 18:49
8d
This is the second installment in a four-part series. LOS ANGELES (MarketWatch) -- Look around the health-care world, and the almighty dollar can rear its head just about anywhere. It’s often seen...
2014/11/17 12:13
2014/11/17 12:13
9d
Twenty-five years after scientists first identified the hepatitis C virus, doctors are declaring victory over an infection that afflicts more than 3 million Americans and kills more of them than...
2014/11/14 23:48
2014/11/14 23:48
12d
Janus Capital Group, Inc. (JNS), formerly one of the largest asset management firms in the world and now hoping for resurgence with the signing of PIMCO founder Bill Gross, sells multiple mutual funds...
2014/11/13 09:17
2014/11/13 09:17
14d
FOSTER CITY, Californie--(BUSINESS WIRE)--Gilead Sciences, Inc. (NASDAQ : GILD) a annoncé aujourd’hui la détermination du prix de billets de premier rang non garantis d’un montant total en principal...
2014/11/12 23:18
2014/11/12 23:18
14d
FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (NASDAQ: GILD) today announced the pricing of senior unsecured notes in an aggregate principal amount of $4 billion, in an underwritten,...
2014/11/12 05:27
2014/11/12 05:27
15d
Hepatitis C drug of Gilead Sciences gets positive results BOSTON - Gilead Sciences, Inc., US biotechnology company, Tuesday announced a high success rate for its new Harvoni drug for hepatitis C...
2014/11/12 00:17
2014/11/12 00:17
15d
Gilead comunica i dati derivati dagli studi condotti su Harvoni per il trattamento di pazienti con infezione cronica da virus dell’epatite C con malattia epatica avanzata e pazienti che non hanno...
2014/11/10 17:49
2014/11/10 17:49
16d
Companies in the S&P 500 Index, despite concerns of a slowdown in global economic growth, are increasing revenue at twice the pace of the U.S. economy. As this is the first month without stimulus...
2014/11/10 17:49
2014/11/10 17:49
16d
LOS ANGELES (MarketWatch) — Two drug makers on vastly different paths both found themselves in negative territory Monday, as Dow component Merck & Co. Inc. slipped on a disappointing drug trial result...
2014/11/10 15:21
2014/11/10 15:21
16d
Bloomberg News Merck & Co. won't move forward with an ultra-short hepatitis C regimen that attempted to cut treatment durations in half by combining two of its drugs with another from Gilead Sciences...
2014/11/07 09:06
2014/11/07 09:06
20d
Next to Alice Gorman’s bed is a small suitcase packed with clothes and a fully charged mobile phone she carries wherever she goes. The news she’s waiting for: a donated liver that matches her blood...
2014/11/07 00:17
2014/11/07 00:17
20d
FOSTER CITY, Californië (VS)--(BUSINESS WIRE)--Gilead Sciences, Inc. (NASDAQ: GILD) heeft vandaag bekendgemaakt dat het bedrijf een nieuwe geneesmiddelaanvraag (New Drug Application, NDA) heeft...
2014/10/31 17:12
2014/10/31 17:12
26d
Since Shire deal collapsed, AbbVie's probably done with mega mergers Health Care Headlines (Bloomberg) — AbbVie Inc. probably won't make another $50 billion-plus deal after walking away from a...
2014/10/31 02:17
2014/10/31 02:17
27d
FOSTER CITY, Californië (VS)--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) heeft vandaag haar bedrijfsresultaten bekendgemaakt voor het kwartaal eindigend op 30 september 2014. De totale...
2014/10/30 09:09
2014/10/30 09:09
28d
U.S. stocks declined Wednesday after the Federal Reserve confirmed it will end its asset-purchase program, indicating the U.S. economy is on a stable growth path. Facebook Inc. fell after forecasts...
2014/11/26 12:45
2014/11/26 12:45
Latest from Twitter